Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    2027 CARRA-Arthritis Foundation Bridge Grant

    The 2027 CARRA-Arthritis Foundation Bridge Grant supports pediatric rheumatology investigators with research funding to address reviewer feedback and prepare revised proposals after unfunded grant decisions.

    Browse similar grants
    Cancer Research Grants 2026
    OverviewSimilar Grants
    OverviewSimilar Grants

    This grant was recently updated

    No changes to the 2027 CARRA-Arthritis Foundation Bridge Grant are shown; the new “Closed Opportunities” heading appears above the separate CARRA Data Analysis Support Grant.

    Funder: Childhood Arthritis and Rheumatology Research Alliance

    Due Dates: December 11, 2026 (Letter of Intent) | March 15, 2027 (Full application)

    Funding Amounts: $125,000 per award for 12–18 months

    Summary: Bridge funding supports pediatric rheumatology investigators revising scored but unfunded career development or investigator-initiated grant applications.

    Key Information: PIs must be current CARRA members and plan to resubmit their unfunded application within 12–18 months.


    Description

    The CARRA-Arthritis Foundation Bridge Grant supports principal investigators between an unfunded grant decision and submission of a revised proposal. It funds research associated with K-equivalent career development or R-equivalent investigator-initiated applications submitted to the National Institutes of Health, Veterans Affairs, Department of Defense, or a similar funding agency. Applicants must have received a scored but unfunded application, including a priority score, summary statement, and funding decision.

    Administered by the Childhood Arthritis and Rheumatology Research Alliance (CARRA), the program supports work that furthers its 2026–2028 Strategic Plan and Research Agenda. Its goal is to unite the pediatric rheumatology community to advance research and transform the lives of children with rheumatic diseases. Projects must describe their direct or indirect benefit to patients while investigators address reviewer feedback and prepare resubmissions.


    Atom

    See the full grant listing

    Sign in to view full eligibility details, sources, similar grants, and AI-powered analysis.